| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.47 | 0.003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.49 | 0.004 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |